Douglas F Kling New Amsterdam Pharma CO N.V. (NAMS) insider trading activity

Shares Held (Direct Ownership) 44K

n/a 3M change

n/a 12M change

Total Value Held N/A

Douglas F Kling Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 30 2025	SELL Open market or private sale	-	13,578 Reduced 23.58%	44,000 Ordinary Shares
Jan 30 2025	BUY Exercise of conversion of derivative security	-	13,578 Added 19.08%	57,578 Ordinary Shares
Jan 29 2025	SELL Open market or private sale	-	56,863 Reduced 56.38%	44,000 Ordinary Shares
Jan 29 2025	BUY Exercise of conversion of derivative security	-	56,863 Added 36.05%	100,863 Ordinary Shares
Jan 28 2025	SELL Open market or private sale	-	25,385 Reduced 36.59%	44,000 Ordinary Shares
Jan 28 2025	BUY Exercise of conversion of derivative security	-	25,385 Added 26.79%	69,385 Ordinary Shares
Jan 27 2025	SELL Open market or private sale	-	104,174 Reduced 70.31%	44,000 Ordinary Shares
Jan 27 2025	BUY Exercise of conversion of derivative security	-	104,174 Added 41.28%	148,174 Ordinary Shares
Jan 07 2025	BUY Grant, award, or other acquisition	-	44,000 Added 50.0%	44,000 Ordinary Shares

DFK

Chief Operating Officer

Naarden, P7

Receive a notification when an Institution or Guru buys or sells NAMS shares.

Notify only if

Value

Get notified when an New Amsterdam Pharma CO N.V. insider buys or sells NAMS shares.

Notify only if

Operation

Value

Type

Receive news related to NewAmsterdam Pharma Co N.V.